Creates a wholesale prescription drug importation program which complies with federal standards and regulations for the purpose of generating substantial savings for consumers.
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.
This bill (S 8756) modifies the implementation timeline for a law allowing close friends to arrange body donations for medical purposes after a person's death. It changes the effective date so that the health commissioner can immediately begin implementing the law - rather than waiting 180 days - upon the bill's passage. This adjustment primarily affects individuals who wish to donate a deceased person's body for medical education or research, ensuring faster administrative readiness. The bill is procedural in nature, focusing solely on implementation timing, not the eligibility for body donations.
Requires anti-bias training for every medical student, medical resident and physician assistant student in the state; requires the department of health to make an annual report on the implementation and effectiveness of such training.
Relates to requirements for medical professionals and health care facilities that provide medication to patients for medical aid in dying; extends the initial effectiveness of certain provisions relating thereto.
This bill establishes New York's "Medical Aid in Dying Act," allowing terminally ill adults (18+) with decision-making capacity to request and self-administer medication to end their life. To qualify, a patient must have a terminal illness confirmed by two physicians (the attending physician and a consulting physician) and make an informed decision after being fully informed of alternatives, risks, and outcomes. The process requires an oral request, a written request signed by the patient and witnessed by two non-conflicted adults (not relatives or beneficiaries), and includes the right to rescind the request at any time. The bill also mandates documentation, safe disposal of unused medication, and state reporting.
Enacts the "public university emergency contraception education act" requiring public universities to develop, produce and distribute informational materials related to emergency contraception.
Provides that the prescribing, dispensing, or receipt of mifepristone or any drug used for medication abortion shall not be considered a criminal conversion act under certain circumstances; provides that mifepristone or any drug used for medication abortion shall not be deemed to be adulterated or misbranded under certain circumstances.
Establishes "The Equity in Fertility Treatment Act"; relates to the definition of infertility and health insurance coverage for the treatment of infertility.
Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.